Cancer Medicines Forum: February 2024
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date: 26 February 2024
End date: 26 February 2024
EventHumanResearch and development

Membership list: HMA-EMA joint Big Data Steering Group

English (EN) (135 KB - PDF)

First published: Last updated:
View

Highlight report - Eleventh industry stakeholder platform on research and development support

Reference Number: EMA/554023/2023

English (EN) (164.52 KB - PDF)

First published:
View
EudraVigilance system overview

EudraVigilance is a system for monitoring the safety of medicines. Its components facilitate electronic reporting of suspected adverse reactions related to medicines and the effective analysis of data. This enables the early detection of potential safety issues.

Last updated:
HumanRegulatory and procedural guidancePharmacovigilanceResearch and development

Agenda - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting

Reference Number: EMA/567941/2023

English (EN) (269.41 KB - PDF)

First published: Last updated:
View
Supporting innovation

A range of services is available from the European Medicines Agency (EMA), Heads of Medicines Agencies (HMA) and European Commission to support innovative medicines and associated technology developments in the European Union (EU).

Last updated:
HumanVeterinaryRegulatory and procedural guidanceInnovationResearch and developmentScientific advice

Agenda - DARWIN EU Advisory Board - 11 December 2023

Reference Number: EMA/423117/2023

English (EN) (124.37 KB - PDF)

First published:
View

Minutes – DARWIN EU Advisory Board - 24 May 2023

Reference Number: EMA/238242/2023

English (EN) (184.19 KB - PDF)

First published:
View